The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing the needs of those who serve the underserved: A national survey among cancer care clinicians.
 
Manali I. Patel
No Relationships to Disclose
 
Janette K. Merrill
No Relationships to Disclose
 
Kimberly Smith
No Relationships to Disclose
 
Daniel R. Carrizosa
Consulting or Advisory Role - Cardinal Health; Curio Science; Sanofi; Sanofi/Regeneron
Speakers' Bureau - Research to Practice
Research Funding - Celgene (Inst); Coordination Pharmaceuticals (Inst); Elevation Oncology (Inst); GlaxoSmithKline (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst)
 
Narjust Florez
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; Janssen; Merck; Mirati Therapeutics; NeoGenomics Laboratories; Pfizer
Speakers' Bureau - MJH Life Sciences
 
Lola A. Fashoyin-Aje
No Relationships to Disclose
 
Scarlett Lin Gomez
Employment - Bioinspire (I); Valent Technologies (I)
Stock and Other Ownership Interests - Amgen (I); Bioinspire (I)
Consulting or Advisory Role - GRAIL
 
Meredith Elana Giuliani
Consulting or Advisory Role - Bristol Myers Squibb Foundation
 
Leslie J. Hinyard
No Relationships to Disclose
 
Fay J. Hlubocky
No Relationships to Disclose
 
Sanford Earl Jeames
No Relationships to Disclose
 
Tricia L. Kalwar
Employment - Broward Health Medical Center; Vohra Wound Physicians (I)
 
Sailaja Kamaraju
Honoraria - Athenex; University of Wisconsin
Consulting or Advisory Role - Pfizer
Research Funding - CONTEXT THERAPEUTICS; Pfizer
Travel, Accommodations, Expenses - Agendia; Pfizer
 
Sheetal Mehta Kircher
Stock and Other Ownership Interests - Abbott/AbbVie; Penrose
 
William D. Tap
Leadership - Atropos; Certis Oncology Solutions; Innovo Therapeutics
Stock and Other Ownership Interests - Atropos; Certis Oncology Solutions
Consulting or Advisory Role - Adcendo; Amgen; Ayala Pharmaceuticals; Bayer; C4 Therapeutics; Cogent Biosciences; Daiichi Sankyo; Deciphera; EMD Serono; Epizyme; Foghorn Therapeutics; Kowa Pharmaceutical; Lilly; Medpacto; Mundipharma; Servier
Research Funding - BioAtla; Blueprint Medicines; Daiichi Sankyo; Deciphera; Immune Design; Lilly; Novartis; Plexxikon; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Companion Diagnostic for CDK4 inhibitors - 14/854,329; Enigma and CDH18 as companion Diagnostics for CDK4 inhibition – SKI2016-021-03